Clinical

Clinical Achievements and Expertise from China

vascular surgery

New Research on ARAS Management: FFR-Guided Stenting Significantly Reduces Unnecessary Procedures for Renovascular Hypertension

October 10, 2025

A recent pilot randomized controlled trial (RCT), the FAIR trial, led by investigators at Beijing University First Hospital and involving 24 centers across China, presents a significant development for the management of atherosclerotic renal artery stenosis (ARAS) and renovascular hypertension. The FAIR trial provides critical evidence that using Fractional Flow Reserve (FFR) can help clinicians select which patients with ARAS are most likely to benefit from a stent, thus supporting the integration of advanced functional diagnostics into percutaneous intervention decision-making, directly addressing a critical gap in global clinical guidelines. The results were published on October 7, 2025 on European Heart Journal.

More to Read

Neurovascular/stroke

Normobaric Hyperoxia Enhances Stroke Recovery: The Results of The OPENS-2 Trials Published on THE LANCET

February 8, 2025

Recently, the results of a multicenter, randomized, single-blind, placebo-controlled trial named “Normobaric Hyperoxia Combined with Endovascular Treatment for Acute Ischemic Stroke (OPENS-2 trial)” are published on THE LANCET. The study results indicate that normobaric hyperoxia combined with endovascular treatment can significantly improve the functional outcomes of patients with acute ischemic stroke, without increasing safety concerns.

More to Read

Neurovascular/stroke

Dr. Yongjun WANG As The First Asian Winner of William M. Feinberg Award, Pioneering Stroke Research at ISC 2025

February 7, 2025

Great news for Chinese clinical scientists in stroke care! Recently, Dr. Yongjun WANG, a distinguished clinical scientist and leader in stroke research from China, has been honored with the prestigious William M. Feinberg Award for Excellence in Clinical Stroke at the 2025 International Stroke Conference (ISC). This award is the first ever presented to an Asian scientist, marking a significant milestone in the recognition of Dr. Wang’s contributions to the field.